Sponsors
The bill extends temporary control over fentanyl-related substances for six months, preserving law-enforcement and public-health tools to address rapidly evolving analogues but at the cost of continued criminal penalties for some individuals, delayed regulatory clarity for researchers and suppliers, and additional enforcement expenses.
Law enforcement can continue using the temporary classification for six more months to prosecute and disrupt fentanyl-analogue trafficking, preserving active interdiction and investigation capacity.
Regulators retain authority to treat newly emerging fentanyl-related substances as controlled during the extension, supporting overdose-prevention and public-health responses to novel analogues.
Ongoing criminal investigations and prosecutions that rely on the temporary scheduling order can continue without interruption, helping to preserve case integrity and evidence chains.
People prosecuted under the extended temporary schedule remain exposed to criminal penalties for substances that are not yet permanently scheduled, disproportionately affecting low-income and marginalized individuals.
The six-month extension delays permanent rulemaking or study conclusions, prolonging regulatory uncertainty for researchers, manufacturers, and suppliers who need clarity about which substances are controlled.
Continued enforcement and interdiction activities during the extension will impose additional federal and state costs, creating incremental taxpayer expense.
Based on analysis of 2 sections of legislative text.
Introduced February 25, 2025 by Cory Anthony Booker · Last progress February 25, 2025
Extends the temporary federal control on fentanyl-related substances for six months by changing the existing expiration date from March 31, 2025 to September 30, 2025. The amendment preserves the current temporary scheduling and regulatory status of fentanyl-related substances for that additional period.